Interleukin 2 (IL-2) promotes Foxp3 + regulatory T (T reg ) cell responses, but inhibits T follicular helper (T FH ) cell development. However, it is not clear how IL-2 affects T follicular regulatory (T FR ) cells, a cell type with properties of both T reg and T FH cells.
IL-2 is essential for the development and maintenance of Foxp3 + CD4 + T reg cells, which prevent autoimmune disease development 1 . The principal mechanism by which IL-2 promotes T reg cell development is by activating the transcription factor STAT5, which binds to the Foxp3 locus and promotes Foxp3 expression [2] [3] [4] . IL-2 signaling is also required to maintain the competitive fitness of T reg cells in secondary lymphoid organs 5, 6 and for reinforcing their suppressive activity 7, 8 . Thus, mice lacking IL-2 or IL-2Rα (CD25) fail to maintain peripheral tolerance, and they develop autoimmune disease 9 .
T reg cells express high amounts of CD25, the α chain of the highaffinity IL-2 receptor, allowing them to effectively compete with other cells for available IL-2 (refs. [10] [11] [12] . Indeed, IL-2 consumption by T reg cells is one of the primary mechanisms by which they prevent effector T cell (T eff ) responses 13 . Conversely, IL-2 consumption by T reg cells facilitates CD4 + T FH cell development 10 , given that IL-2 signaling inhibits T FH cell differentiation [14] [15] [16] . Notably, some activated T reg cells downregulate CD25 and do not require IL-2 for their homeostatic maintenance 17 . Instead, their survival is dependent on interactions between the co-stimulatory receptors ICOS and ICOS-L 17 . Similarly, antigen-experienced T reg cells in the skin 18 and in aged mice 19 express less CD25, and depend on interleukins 7 and 15 (IL-7 and IL-15) rather than IL-2 for their maintenance, suggesting that IL-2 might be dispensable for the homeostasis of some T reg cell subsets.
Notably, some Foxp3-expressing T reg cells upregulate Bcl-6 and CXCR5, molecules that are normally expressed by T FH cells 20, 21 . These Foxp3 + Bcl-6 + CXCR5 + CD4 + cells are known as T FR cells [20] [21] [22] , which migrate to B cell follicles, where they suppress B cell responses [20] [21] [22] [23] [24] [25] . The ability of T FR cells to coexpress Foxp3 and Bcl-6 is somewhat surprising, as IL-2 signaling is important for Foxp3 expression, but inhibits Bcl-6 (refs. 14, 15, 26) . Thus, it is unclear how IL-2 might be involved in the differentiation or maintenance of T FR cells.
We investigated the role of IL-2 in T FR cell responses to influenza. We found that high concentrations of IL-2 at the peak of the infection promoted the expression of the transcriptional repressor Blimp-1 in T reg cells, which suppressed Bcl-6 expression and thereby precluded T FR cell development. As a consequence, T FR cells failed to accumulate at the peak of the influenza infection. However, once the virus was eliminated and IL-2 concentrations declined, some CD25 hi T reg cells downregulated CD25, upregulated Bcl-6 and differentiated into T FR cells, which migrated into the B cell follicles to prevent the accumulation of self-reactive B cell clones. Collectively, our data indicate that IL-2 signaling differentially controls conventional T reg and T FR cell responses to influenza virus, and reveal an important role for T FR cells in maintaining B cell tolerance after influenza infection.
RESULTS

Kinetics of T FR cell expansion following influenza infection
To evaluate whether T FR cells could be detected after influenza infection, we intranasally (i.n.) infected C57BL/6 (B6) mice with influenza A/PR8/34 (PR8) and characterized Foxp3 + CD4 + T cells in the lung-draining mediastinal lymph node (mLN) 30 d later ( Fig. 1a-c) . Foxp3 + CD69 lo CD4 + cells expressed low amounts of Bcl-6 and the chemokine receptor CXCR5 (Fig. 1a) . In contrast, Foxp3 + CD69 hi CD4 + T cells could be separated into Bcl-6 lo CXCR5 lo cells, which showed low expression of the co-stimulatory molecule PD-1 and the germinal center marker GL-7, and Bcl-6 hi CXCR5 hi cells, which showed high expression of PD-1 and GL-7 ( Fig. 1a-c) . Thus, we designated the Bcl-6 lo CXCR5 lo Foxp3 + CD4 + T cells as conventional T reg cells and A r t i c l e s Bcl-6 hi CXCR5 hi Foxp3 + CD4 + T cells as T FR cells. T FR cell development requires SLAM-associated protein (SAP)-mediated interaction with B cells 21 . As such, the frequency and number of Bcl-6 hi CXCR5 hi T FR cells were decreased in SAP-deficient (B6.Sh2d1a −/− ) mice relative to B6 mice ( Fig. 1d,e ). Finally, to determine whether Foxp3 + cells home to germinal centers (GCs) following influenza infection, we examined the placement of Foxp3 + cells relative to B cell follicles and GCs in sections of mLNs obtained from mice infected with influenza for 30 d (Supplementary Fig. 1a ). As expected, we identified CD4 + Foxp3 + cells in the B cell follicles, the interfollicular area and inside the GCs (Supplementary Fig. 1a,b) . These results indicate that bona fide T FR cells develop following influenza virus infection.
We next infected B6 mice with influenza and enumerated T FR cells and conventional T reg cells in the mLN at different times after infection ( Fig. 1f-h) . Bcl-6 hi CXCR5 hi T FR cells were barely detectable at the peak of the infection (day 7-15), but largely accumulated during the late phase of the primary response (day 30-60) ( Fig. 1f,g) . In contrast, conventional T reg cells rapidly expanded between days 3 and 7 (Fig. 1h) . Notably, the paucity of T FR cells at the peak of the infection was not a result of a lack of GC B cells, as GC B cells were easily detected at day 10, continued to expand through day 15 and declined thereafter (Fig. 1i,j) . We also observed that Bcl-6 hi CXCR5 hi T FH cells ( Fig. 1k,l) peaked between days 7 and 15 after infection, and subsequently contracted between days 15 and 30. Thus, in contrast with GC cells, T FH cells and conventional T reg cells, T FR cells fail to accumulate at the peak of the infection.
To further confirm this conclusion, we evaluated the presence of Foxp3 + cells in the GCs at days 10 and 30 after infection by immunohistochemistry ( Supplementary Fig. 1c ). Foxp3 + cells were easily detected in the B cell follicles, interfollicular area and GCs on day Figure 1 Kinetics of the T FR cell response to influenza. (a-c) B6 mice were infected with PR8 and cells from the mLN were analyzed by flow cytometry 30 d after infection. (a) Expression of Bcl-6 and CXCR5 in FoxP3 + CD69 hi and FoxP3 + CD69 lo CD4 + T cells. Expression of PD-1 (b) and GL-7 (c) on Bcl-6 lo CXCR5 lo and Bcl-6 hi CXCR5 hi FoxP3 + CD69 hi CD4 + T cells. Data are representative of five independent experiments (3-5 mice per experiment). (d,e) B6 and B6.Sh2d1a −/− mice were infected with PR8 and the frequency (d) and number (e) of FoxP3 + CD69 hi CD4 + T cells with a Bcl-6 hi CXCR5 hi T FR cell phenotype were evaluated in the mLN 30 d after infection. Data are representative of three independent experiments (mean ± s.d. of 3-5 mice per group). ***P < 0.001. P values were determined using a two-tailed Student's t test. (f-l) B6 mice were infected with PR8 and cells from the mLN were analyzed by flow cytometry at the indicated time points. Frequency (f) and number (g) of Bcl-6 hi CXCR5 hi T FR cells. Representative plots were gated on FoxP3 + CD69 hi CD19 − CD4 + T cells. (h) Number of FoxP3 + CD69 hi T reg cells with a Bcl-6 lo CXCR5 lo phenotype. Frequency (i) and number (j) of CD19 + CD138 − PNA hi CD95 hi GC B cells. Frequency (k) and number (l) of Bcl-6 hi CXCR5 hi T FH cells. Representative plots were gated on CD4 + FoxP3 − CD19 − T cells. Data are shown as the mean ± s.d. (n = 4-5 mice per time point). Data are representative of three independent experiments. 30 . By contrast, very few Foxp3 + cells were present in the GCs at day 10, despite being abundant in the T cell area. Collectively, these results indicate that the T FR cells fail to develop during the peak of the influenza infection, but instead accumulate in the mLN at later time points.
Previous studies have shown that T FR cells develop quickly (days 7-14) following immunization with soluble antigens 20, 21, 23 . To determine whether the delayed appearance of T FR cells is unique to influenza, we enumerated T FR cells in B6 mice that were either immunized with influenza hemagglutinin (HA) adsorbed to alum ( Supplementary  Fig. 1d ,e) or infected with LCMV-Armstrong ( Supplementary  Fig. 1f,g) . Consistent with the published studies, we found that T FR cells were readily detected at day 9 after HA immunization and were maintained for at least 30 d ( Supplementary Fig. 1d,e ). By contrast, T FR cells were virtually undetectable at day 9 following LCMV-Armstrong infection, but accumulated in large numbers at day 30 after infection ( Supplementary Fig. 1f,g A r t i c l e s soluble protein immunization, T FR cells fail to differentiate at the peak of acute viral infections.
T FR cells exhibit low expression of CD25
T FR cells depend on Bcl-6 (refs. [20] [21] [22] , whose expression is inhibited by IL-2 (refs. 10, 14, 16) . To examine the relationship between T FR cells and IL-2 signaling, we divided the CD69 + Foxp3 + CD4 + T cell population into CD25 hi and CD25 lo cells and analyzed the expression of T FR cell markers in these subpopulations ( Fig. 2a-c) .
We found that CD25 lo Foxp3 + cells, but not CD25 hi Foxp3 + cells, upregulated T FR markers following infection ( Fig. 2a-c) . Notably, although CD25 lo Foxp3 + cells were present at the peak of the infection (day 10), they expressed low amounts of CXCR5, Bcl-6 and PD-1 relative to later time points, suggesting that a lack of T FR cells at the peak of the infection was not a result of a lack of CD25 lo Foxp3 + cells (Supplementary Fig. 2a-c) . Similar results were obtained in LCMV-infected mice or HA-Alum-immunized mice ( Supplementary   Fig. 2d,e ). Thus, unlike conventional T reg cells, which are CD25 hi , T FR cells are CD25 lo . We next evaluated STAT5 phosphorylation in T FR and conventional T reg cells and found that phosphorylation of STAT5 was reduced in T FR cells compared with conventional T reg cells ( Fig. 2d ), suggesting that T FR and conventional T reg cells respond differently to IL-2. To confirm this conclusion, we sorted conventional T reg cells (Foxp3 + CD69 hi PD-1 lo CX-CR5 lo CD25 hi ) and T FR cells (Foxp3 + CD69 hi PD-1 hi CXCR5 hi CD25 lo ) from the mLN of B6.Foxp3-DTR-GFP mice 30 d after infection and performed RNA sequencing (RNA-seq) and gene set enrichment analysis (GSEA) to identify hallmark signaling pathways that were differentially enriched in these populations ( Fig. 2e,f ). Approximately 2,000 genes were differentially expressed between conventional T reg and T FR cells ( Supplementary Table 1 ). Notably, the IL-2-STAT5 signaling pathway had the highest normalized enrichment score (NES = 3.54, FDR < 0.001) and contained the largest number of genes upregulated in T reg cells relative to T FR cells ( Fig. 2e) . Of the 200 genes The number of donor-derived CD45.1 + CD69 + FoxP3 + T cells with a Bcl-6 hi CXCR5 hi phenotype in recipients receiving CD25 hi FoxP3 + and CD25 lo FoxP3 + cells are shown. Data were pooled from two independent experiments (mean ± s.d.). **P < 0.01. P values were determined using a two-tailed Student's t test. (g,h) Equivalent numbers of sorted CD25 hi FoxP3 + and FoxP3 − CD4 + T cells obtained from the spleen of naive CD45.2 + B6-Foxp3-DTR-GFP mice were adoptively transferred into Tcrb −/− Tcrd −/− recipient mice. The recipient mice also received purified CD4 + and CD8 + T cells from the spleen of naïve CD45.1 + B6 mice. We infected mice 1 d later with influenza and assessed the donor-derived CD45.2 + CD69 + FoxP3 + CD4 + T cells in the mLN on day 30 by flow cytometry. Frequency (g) and number (h) of CD45.2 + CD69 + FoxP3 + T cells with a Bcl-6 hi CXCR5 hi phenotype in recipients of CD25 hi FoxP3 + and FoxP3 − CD4 + T cells. **P < 0.01. P values were determined using a two-tailed Student's t test. (i) Frequencies of Bcl-6 hi CXCR5 hi in CD25 hi and CD25 lo FoxP3 + cells derived from the CD45.2 + CD25 hi Foxp3 + donors. Data are representative of two independent experiments. Data are shown as the mean ± s.d. (n = 3-5 mice).
in the hallmark IL-2-STAT5 signaling pathway, 72 were significantly downregulated in T FR versus T reg cells ( Fig. 2f and Supplementary  Tables 2 and 3 ). Despite their low expression of CD25 ( Fig. 2g) , T FR cells expressed high amounts of IL-2Rβ (CD122; Fig. 2h ), suggesting that T FR cells may have some remaining capacity to respond to IL-2, particularly when its physiological concentration is sufficiently high 27 . Altogether, our results indicate that the IL-2-STAT5 signaling pathway is downregulated in T FR cells compared with conventional T reg cells. A r t i c l e s CD25 + T reg cells are the precursors of T FR cells Previous studies have shown that T FR cells differentiate from preexisting Foxp3 + T reg precursors 20, 21 . Given that T FR cells were CD25 lo , we used adoptive-transfer experiments to test whether T FR cells are derived from pre-existing CD25 hi Foxp3 + or CD25 lo Foxp3 + T cells. Thus, we sorted CD25 hi Foxp3 + or CD25 lo Foxp3 + CD4 + T cells from the spleens of naive B6.Foxp3-DTR-GFP (CD45.2 + ) mice, which express the diphtheria-toxin receptor and the eGFP genes under the control of the Foxp3 promoter, and adoptively transferred equivalent numbers of these cells into naive Tcrb −/− Tcrd −/− mice, which lack T cells. We also transferred total CD8 + and CD4 + T cells from B6.CD45.1 mice to provide a competent T cell environment. We infected mice 1 d later with influenza, and characterized the donor-derived Foxp3 + cells 30 d later. The frequencies and numbers of activated Foxp3 + cells derived from the CD45.2 + donors were increased in recipients of CD25 hi Foxp3 + cells compared with recipients of CD25 lo Foxp3 + cells (Fig. 3a,b) . We also found that nearly 6% of the progeny derived from CD25 hi Foxp3 + cells upregulated Bcl-6 and CXCR5, whereas few of the progeny derived from CD25 lo Foxp3 + cells upregulated Bcl-6 and CXCR5 (Fig. 3c) . As a result, the numbers of CD45.2 + T FR cells were significantly higher in recipients of CD25 hi Foxp3 + cells than in recipients of CD25 lo Foxp3 + cells (Fig. 3d) . Notably, the number of CD45.1 + Foxp3 + cells, and the number of CD45.1 + T FR cells were similar in the two groups (Fig. 3e,f) . These data indicate that preexisting CD25 hi Foxp3 + cells, but not pre-existing CD25 lo Foxp3 + cells, differentiate into T FR cells following influenza infection. Recent data suggest that T FR cells can also be derived from CD4 + Foxp3 − precursors 28 . Thus, we performed adoptive-transfer experiments to compare the capacity of CD4 + Foxp3 − and CD25 hi Foxp3 + cells to differentiate into T FR cells following infection. Although some CD4 + Foxp3 − cells upregulated Foxp3 after infection (data not shown), CD45.2 + T FR cells were only generated from CD25 hi Foxp3 + cell precursors (Fig. 3g,h) . Collectively, these data indicate that CD25 hi Foxp3 + cells are the precursors of T FR cells after influenza infection.
We next tested whether the Foxp3 + cells derived from the CD25 hi Foxp3 + donors maintained CD25 expression ( Fig. 3i) . We found that, although the majority of Foxp3 + progeny derived from the CD25 hi Foxp3 + donors were CD25 hi , some cells lost expression of CD25 and only the CD25 lo cells upregulated T FR markers (Fig. 3i) . Collectively, these results suggest that a fraction of the activated CD25 + Foxp3 + CD4 + T cells downregulate CD25 and upregulate Bcl-6, PD-1 and CXCR5 late after infection.
IL-2 signaling precludes T FR cell development
Given that IL-2 signaling inhibits Bcl-6 expression 10,14,16 , we next tested whether T FR cells can develop in a high-IL-2 environment. To do this, we infected B6 mice with influenza, treated them with either 30,000 units (U) of recombinant IL-2 (rIL-2) or phosphate-buffered saline (PBS) for nine consecutive days starting on day 20 and enumerated T FR cells in the mLN on day 30. As a control, we analyzed mice that had been infected for 10 d. As expected, the frequencies and numbers of T FR cells were higher in mice infected for 30 d relative to mice infected for 10 d (Fig. 4a,b) . By contrast, T FR cells failed to accumulate in rIL-2-treated mice (Fig. 4a,b ), suggesting that a high-IL-2 environment prevents the accumulation of T FR cells.
We next determined the kinetics of IL-2 production during influenza infection using Il21-mCherry-Il2-emGFP dual reporter transgenic mice 29 (Fig. 4c) . We found that the frequency of IL-2-producing CD4 + T cells peaked at day 10 and declined thereafter (Fig. 4c) . We also found that the frequency of IL-2-producing CD4 + T cells was significantly increased in mice that had been infected with influenza for 10 d relative to mice that had been immunized with HA for 10 d (Supplementary Fig. 3) . Given that IL-2 is highly produced at the peak of the infection, we hypothesized that strong IL-2 signals prevented the differentiation of T FR cells at this time. To address this possibility, we infected B6 mice with influenza, treated them daily from day 3 to day 9 with neutralizing IL-2 antibodies (JES6-1A12 + S4B6-1) or control antibody (2A3), and analyzed the Foxp3 compartment in the mLN on day 10 (Fig. 4d,e) . As expected, we detected very few T FR cells in control-treated mice. The frequency and number of T FR cells was, however, significantly increased in the anti-IL-2-treated mice (Fig. 4d,e) . These results suggest that an elevated concentration of IL-2 at the peak of the infection prevents Foxp3-expressing cells from differentiating into T FR cells. We also found more T FH cells, but less conventional CD25 + T reg cells, in the anti-IL-2-treated mice compared A r t i c l e s with control mice (Fig. 4f-h) , which is consistent with previous studies showing that IL-2 signaling is required for CD25 hi Foxp3 + T reg cell expansion 2,7,30-32 , but prevents T FH cell differentiation [14] [15] [16] 26 .
To confirm that IL-2 signaling inhibits T FR cell differentiation, we sorted CD25 hi Foxp3 + cells from B6.Foxp3-DTR-GFP mice infected with influenza for 7 d, activated them in vitro with anti-CD3 and anti-CD28 beads in the presence of high (200 U ml −1 ) or low (5 U ml −1 ) rIL-2 concentrations, and assessed the phenotype of Foxp3 + cells 3 d later ( Fig. 4i-o) . Foxp3 + cells activated in the presence of high-IL-2 concentrations expressed high levels of CD25, Blimp-1 and the transcription factor T-bet relative to Foxp3 + cells cultured in low-IL-2 conditions (Fig. 4i-k) . In contrast, Bcl-6 and CXCR5 were upregulated in Foxp3 + cells cultured in low-IL-2 concentrations (Fig. 4l,m) . As a result, Bcl-6 hi CXCR5 hi cells differentiated in the low, but not high, IL-2 cultures (Fig. 4n,o) . Collectively, our data indicate that, although elevated IL-2 signaling at the peak of the infection promotes CD25 hi T reg cell responses, it simultaneously prevents Foxp3-expressing cells from upregulating Bcl-6 and CXCR5 and differentiating into T FR cells. -1 (refs. 14,15 ) and by favoring the formation of T-bet-Bcl-6 complexes, which mask the Bcl-6 DNA-binding domain and prevent it from binding to its target genes 26 . Thus, we next assessed the expression of these transcription factors in Foxp3 + cells following influenza infection (Fig. 5a-c) . To do this, we infected B6.Blimp-1-YFP reporter mice and examined the expression of the Blimp-1-YFP reporter in CD69 + Foxp3 + CD4 + T cells (Fig. 5a,b) . We found that nearly 12% of these cells were Blimp-1-YFP + (Fig. 5a) . As predicted, Blimp-1-YFP + cells were Bcl-6 lo (Fig. 5a) . We also found that, although some Blimp-1-YFP + cells were CD25 int/low , the majority of Blimp-1-YFP + cells expressed high amounts of CD25 (Fig. 5b) . We next analyzed T-bet expression and found that it was highly expressed in CD25 hi Blimp-1 + cells relative to CD25 lo Blimp-1 − cells (Fig. 5c) . Thus, consistent with previous studies [33] [34] [35] , T reg cells express T-bet and Blimp-1 following influenza infection.
IL-2 prevents T FR cell responses by promoting Blimp-1 IL-2 inhibits Bcl-6 expression by upregulating Blimp
To investigate the role of these transcription factors in T FR cell development, we made mixed bone marrow (BM) chimeras in which irradiated Tcrb −/− Tcrd −/− recipient mice were reconstituted with a 50:50 mixture of BM obtained from CD45.1 + wild-type and CD45.2 + Tbx21 −/− (T-bet deficient) B6 donor mice. We infected the chimeras 2 months later with influenza and determined the frequency of T FR cells derived from each donor 10 d later. As expected, we failed to detect Bcl-6 hi CXCR5 hi cells in the CD25 hi Foxp3 + compartment of either donor (Fig. 5d) . Although we did observe approximately 5% Bcl-6 hi CXCR5 hi cells in the CD25 lo Foxp3 + compartment, there was no difference between the wild-type and Tbx21 −/− donor cells ( Fig. 5d) . These results suggest that T-bet does not prevent T FR cell differentiation at the peak of the infection.
To address a potential role for Blimp-1 in preventing T FR differentiation, we generated mixed BM chimeras using wild-type (CD45.1 + ) and Prdm1 fl/fl -Lck-cre/+ (CD45.2 + ) donors (WT-Prdm1 −/− chimeras). After reconstitution, chimeras were infected with PR8 and analyzed on day 10. As expected, very few wild-type CD25 lo Foxp3 + cells expressed T FR markers on day 10 post-infection. However, 20% of the Prdm1 −/− CD25 lo Foxp3 + cells were T FR cells (Fig. 5e) . These results suggest that Blimp-1 prevents the development of T FR cells at the peak of the influenza infection.
Finally, we examined whether IL-2 prevents T FR cell differentiation via a Blimp-1-dependent mechanism. Thus, we infected WT-Prdm1 −/− chimeras with influenza, treated them daily with rIL-2 or control PBS starting at day 20, and assessed the T FR cell response in the wild-type and Prdm1 −/− compartments on day 30 after infection ( Fig. 5f,g) . Similar to our prior experiment, we found more CD25 lo Foxp3 + cells with a T FR cell phenotype in the Prdm1 −/− compartment relative to the wild-type compartment in the PBS-treated mice (Fig. 5f) . We also found diminished frequencies of T FR cells in the wild-type compartment of the rIL-2-treated mice relative to PBS-treated mice (Fig. 5f) . However, we observed similar frequencies of Prdm1 −/− T FR cells in both PBS control and IL-2-treated mice (Fig. 5f) . As a consequence, the ratio of Prdm1 −/− to wild-type T FR cells was increased in the rIL-2-treated mice compared with PBS control counterparts (Fig. 5g) . These results indicate that high-IL-2 signaling directly prevents T FR cell differentiation by an intrinsic IL-2/Blimp-1-dependent mechanism. A r t i c l e s T FR cells maintain B cell tolerance after infection We next used three independent approaches to test the effect of T FR cells on the B cell response to influenza. First, we crossed Bcl-6 fl/fl mice 36 to Foxp3 YFP/Cre mice 37 to generate Bcl-6 fl/fl Foxp3 YFP/Cre mice, in which the zinc finger domains of Bcl-6 are conditionally deleted in Foxp3-expressing T cells 36 . Bcl-6 fl/fl Foxp3 YFP/Cre mice were infected with influenza and analyzed on day 30. As expected, the number of T FR cells was reduced in Bcl-6 fl/fl Foxp3 YFP/Cre mice compared with control mice (Fig. 6a,b) . In contrast, T FH cells normally accumulated in Bcl-6 fl/fl Foxp3 YFP/Cre mice (Fig. 6c,d) . Similar results were obtained when we used fluorochrome-labeled MHC class II tetramers to identify influenza nucleoprotein (NP)-specific T FH cells ( Supplementary  Fig. 4a,b) . We also found that GC B cells accumulated normally in control and Bcl-6 fl/fl Foxp3 YFP/Cre mice (Fig. 6e,f) . Notably, however, the frequency and number of CD138 + antibody-secreting cells (ASCs) were increased in Bcl-6 fl/fl Foxp3 YFP/Cre mice relative to control mice (Fig. 6g,h) . These results suggest that lack of T FR cells do not change T FH cell or the GC B cell responses, but instead promote the accumulation of CD138 + ASCs.
To confirm this observation, we generated BM chimeras in which T FR cells were selectively depleted after diphtheria toxin (DT) administration ( Fig. 7a-f) . Thus, we reconstituted irradiated Tcrb −/− Tcrd −/− recipient mice with a 50:50 mix of Cxcr5 −/− and Foxp3-DTR BM (Foxp3-Cxcr5 −/− chimeras), or wild-type BM and Foxp3-DTR BM (Foxp3-WT chimeras). Because T FR cells cannot be produced from Cxcr5 −/− precursors 20 , all of the T FR cells in the influenza-infected Foxp3-Cxcr5 −/− chimeras developed from the Foxp3-DTR donors (Fig. 7a) . In contrast, T FR cells in the Foxp3-WT chimeras developed equally from the WT and Foxp3-DTR donors (Fig. 7a) . As a consequence, T FR cells were depleted following DT administration in the Foxp3-Cxcr5 −/− mice, but not in the Foxp3-WT influenzainfected chimeras (Fig. 7b,c) . The T reg cell response was, however, similar in the two groups (Fig. 7d) . Thus, we infected the chimeric mice with influenza, treated them with DT every 4 d starting on day 15, and enumerated T FH cells, GC B cells and CD138 + ASCs on day 50 in the mLN. We found similar frequencies and numbers of T FH cells and GC B cells (Supplementary Fig. 5a-d) in the DT-treated Foxp3-Cxcr5 −/− and Foxp3-WT chimeras. However, CD138 + ASCs accumulated at a greater frequency in Foxp3-Cxcr5 −/− chimeras than in Foxp3-WT controls (Fig. 7e,f) . Notably, no differences were detected between PBS-treated Foxp3-Cxcr5 −/− and Foxp3-WT chimeras ( Supplementary Fig. 5e ). These findings indicate that a lack of T FR cells promotes the expansion of CD138 + ASCs.
To confirm our observations, we treated influenza-infected B6 mice daily with 15,000 U of rIL-2 starting on day 20 to deplete T FR cells, and evaluated the B cell response in the mLN on day 30. T FR cells were significantly depleted in rIL-2-treated mice (Supplementary Fig. 5f) . In contrast, rIL-2 treatment did not affect the accumulation of total or NP-specific T FH cells at this time and dosage ( Supplementary  Fig. 5g-j) . Similarly, the GC B cell response was similar in PBS and rIL-2 treated mice ( Supplementary Fig. 5k,l) . In contrast, the frequencies and numbers of CD138 + ASCs were increased in rIL-2-treated mice (Fig. 7g,h) . Collectively, our data indicate that absence of T FR cells late after infection promotes the expansion of CD138 + ASCs.
Lack of T FR cell promotes the outgrowth of self-reactive B cell clones following immunization with T-dependent antigens 21 .
To characterize the role of T FR cells in controlling the influenzaspecific B cell response, we used fluorochrome-labeled recombinant NP-tetramers 10, 16 to identify NP-specific B cells in IL-2-treated and Bcl-6 fl/fl Foxp3 YFP/Cre mice (Fig. 8a-h) . The frequencies and numbers of NP-specific GC B cells were similar in control and rIL-2-treated mice (Fig. 8a,b) . In contrast, although 30% of the CD138 + ASCs were NP specific in control mice, only 8% of the CD138 + ASCs were NP specific in the rIL-2-treated mice (Fig. 8c) . As a consequence, the number of NP-specific CD138 + ASCs was similar in control and rIL-2-treated mice (Fig. 8d) . Similar results were obtained when comparing Bcl-6 fl/fl Foxp3 YFP/Cre and control counterparts (Fig. 8e,f) . Finally, the titers of influenza-specific serum IgG were similar in PBS and rIL-2-treated mice (Fig. 8g) or when we compared the serum from Bcl-6 fl/fl Foxp3 YFP/Cre and control mice (Fig. 8h) . These results suggest that a lack of T FR cells does not significantly affect the influenzaspecific B cell response, but instead promotes the accumulation of non-influenza-specific CD138 + ASCs.
We next hypothesized that these ASCs represent the differentiated daughter cells of self-reactive B cells that are known to be generated in the GCs during infections 38 . To test this possibility, we first enumerated histone-specific, IgG-secreting cells by ELISPOT in the mLNs of day-30-infected PBS-and rIL-2-treated mice. As expected, we found very few histone-specific ASCs in the mLN of PBS-treated mice (Fig. 8i) . In contrast, the frequency of anti-histone, IgG ASCs was increased in rIL-2-treated mice, suggesting that a lack of T FR cells results in the development of anti-nuclear antibody (ANA) responses (Fig. 8i) . Thus, we evaluated the serum samples for ANA reactivity. As expected, PBS-treated control mice lacked ANAs, whereas IL-2treated mice were ANA positive ( Fig. 8j) . Finally, we evaluated the presence of ANAs in the serum of Bcl-6 fl/fl Foxp3 YFP/Cre mice. We found that, although the sera from B6-infected mice (Fig. 8k) or naive Bcl-6 fl/fl Foxp3 YFP/Cre mice (Supplementary Fig. 6 ) were negative for ANA staining, the sera obtained from day-30-infected Bcl-6 fl/fl Foxp3 YFP/Cre mice were positive (Fig. 8k) . Thus, our data indicate that T FR cells prevent the expansion of self-reactive ASCs after influenza infection.
DISCUSSION
We found that T FR cells are characterized by low expression of CD25 and that IL-2 signaling inhibits, rather than promotes, the development of T FR cells. Correspondingly, T FR cells fail to accumulate at the peak of the influenza infection, a time during which IL-2 is highly produced. However, after IL-2 withdrawal, some Foxp3 + cells downregulate CD25, upregulate Bcl-6, express CXCR5 and differentiate into T FR cells, which migrate into the B-cell follicles to prevent selfreactive B-cell responses. Thus, unlike conventional T reg cells, high-IL-2 signaling precludes T FR cell development. Notably, IL-2 consumption by CD25 + T reg cells is required for the initial development of virus-specific T FH cells 10 . Thus, IL-2 consumption acts as a rheostat that, although facilitating virus-specific T FH cell responses, selectively prevents T FR cell development at the peak of the infection.
T FR cells prevented self-reactive ASCs, but had no substantial effect on the influenza-specific B cell response, suggesting that T FR cells may be self specific rather than influenza specific. This idea is consistent with data showing that the TCR repertoire of T FR cells is skewed toward self-antigens 39 , as is the TCR repertoire of thymic T reg cells 40, 41 , which we found were the likely precursors of T FR cells after influenza infection. However, T FR cells prevent antigenspecific B cell responses following immunization with soluble antigens, suggesting that antigen-specific T FR cells can develop under some circumstances 20, 21, 23, 28 . In this regard, a recent study suggests that a fraction of the T FR cells differentiate from naive T cell precursors following immunization and are specific for the immunizing Ag 28 . Thus, depending on the specific nature of the immune response, T FR cells can prevent foreign and self-reactive B cell responses based on their origin and TCR specificity. In any case, the capacity of T FR cells to prevent influenza-specific effector B responses is overcome in the context of influenza infection. Indeed, influenza-NP is normally complexed with viral RNA 42 , which targets it to the intracellular Toll-like receptor 7 compartment following BCR stimulation 43 . Thus, it is possible that co-ligation of the BCR and pathogen-recognition receptors in virus-specific B cells synergize to overcome T FR -mediated suppression during influenza infection.
We found that Blimp-1, but not T-bet, suppressed T FR cell development. However, we failed to detect Bcl-6 upregulation in CD25 hi T reg cells, even in Blimp-1-deficient cells, suggesting that Bcl-6 expression in CD25 hi cells is prevented by additional Blimp-1-independent mechanisms. Given that STAT5 binds to the Bcl-6 promoter and directly represses Bcl-6 expression in response to high-IL-2 signaling 26, [44] [45] [46] , it is likely that strong IL-2 signaling through CD25 prevents Bcl-6 expression by a direct STAT5-dependent mechanism.
Our data showing that IL-2 prevents T FR cell responses conflict with the notion that IL-2-STAT5 signaling is required for maintaining Foxp3 expression 1 . However, T FR cells express high amounts of CD122. Thus, although insufficient for inducing sustained Blimp-1 expression in low-IL-2 environments, basal IL-2-STAT5 signaling through the intermediate-affinity IL-2R may be sufficient to prevent Foxp3 downregulation in T FR cells. Alternatively, T FR cell homeostasis may be partially independent of IL-2, but may require signals from other common-γ chain cytokines and co-stimulatory molecules, such as IL-7, IL-15 or ICOS, which can contribute toward the maintenance of Foxp3-expressing cells in the absence of IL-2 (refs. 18, 19, 47, 48) . In any case, it is likely that conventional CD25 + T reg and T FR cells use different cellular and molecular pathways for their homeostatic maintenance.
In summary, our data demonstrate that IL-2 signaling temporarily inhibits T FR cell responses during influenza infection. However, once the immune response is resolved, T FR cells differentiate and home to B cell follicles, where they are required for maintaining B cell tolerance after infection. Thus, the same mechanism that promotes conventional T reg cell responses, namely IL-2 signaling, also prevents T FR cell formation. Collectively, our data provide a new perspective into how IL-2 dynamically regulates T reg cell homeostasis and function along the course of a relevant pathogen infection.
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